Doxorubicin/eribulinLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75796-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[1] EribulinLack of efficacy: case report
Reactions Weekly, 2022, 1919 (1) : 263 - 263
[2] EribulinLack of efficacy following off-label use: case report
Reactions Weekly, 2022, 1921 (1) : 135 - 135
[3] Carboplatin/EribulinLack of efficacy
Reactions Weekly, 2024, 2003 (1) : 220 - 220
[4] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 151 - 151
[5] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 185 - 185
[6] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 228 - 228
[7] Doxorubicin/olaratumabLack of efficacy: case report
Reactions Weekly, 2022, 1893 (1) : 128 - 128
[8] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1936 (1) : 204 - 204
[9] Doxorubicin/IfosfamideLack of efficacy: case report
Reactions Weekly, 2025, 2044 (1) : 131 - 131
[10] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 187 - 187

← 1 2 3 4 5 →